Janssen J W, Lyons J, Steenvoorden A C, Seliger H, Bartram C R
Nucleic Acids Res. 1987 Jul 24;15(14):5669-80. doi: 10.1093/nar/15.14.5669.
DNA transfection analyses (tumorigenicity assay) and hybridization to mutation specific oligonucleotide probes established point mutations in codon 61 of both, N-ras and Ki-ras genes in fresh leukemic cells of an AML patient. Concurrent activation of N-ras and Ki-ras sequences by point mutations in codons 12 were demonstrated for AML cell line Rc2a. Moreover, using a rapid and sensitive dot-blot screening procedure based on the combination of in vitro amplification of ras specific sequences and oligonucleotide hybridization we could show that ras gene activation was not present in primary leukemic cells of the patient this cell line had been derived from, but rather occurred during later passages of Rc2a.
DNA转染分析(致瘤性测定)以及与突变特异性寡核苷酸探针的杂交确定了一名急性髓系白血病(AML)患者新鲜白血病细胞中N-ras和Ki-ras基因第61密码子的点突变。对于AML细胞系Rc2a,证实了第12密码子的点突变同时激活了N-ras和Ki-ras序列。此外,使用基于ras特异性序列体外扩增和寡核苷酸杂交相结合的快速灵敏斑点印迹筛选程序,我们发现该细胞系所源自的患者原发性白血病细胞中不存在ras基因激活,而是在Rc2a的后续传代过程中发生的。